These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27569958)

  • 21. The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups.
    Gailiene G; Pavilonis A; Kareiviene V
    Medicina (Kaunas); 2007; 43(1):36-42. PubMed ID: 17297282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa.
    Fujimura S; Nakano Y; Sato T; Shirahata K; Watanabe A
    J Infect Chemother; 2007 Jun; 13(3):147-50. PubMed ID: 17593500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015-2016.
    Sader HS; Castanheira M; Duncan LR; Flamm RK
    Diagn Microbiol Infect Dis; 2018 Sep; 92(1):69-74. PubMed ID: 29789189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pseudomonas aeruginosa: a multicenter study in 136 hospitals in Spain].
    Bouza E; Garcia-Garrote F; Cercenado E; Marín M; Díaz MS; Sánchez Romero I; Vindel A;
    Rev Esp Quimioter; 2003 Mar; 16(1):41-52. PubMed ID: 12750756
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Pragsam AK; Kumar DT; Doss CGP; Iyadurai R; Satyendra S; Rodrigues C; Joshi S; Roy I; Chaudhuri BN; Chitnis DS; Tapan D; Veeraraghavan B
    Indian J Med Microbiol; 2018; 36(1):127-130. PubMed ID: 29735843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015].
    Hao D; Hu Z; Liu X; Sun T; Wang T; Tian H; Wang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):439-44. PubMed ID: 29920041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic consumption to detect epidemics of Pseudomonas aeruginosa in a burn centre: A paradigm shift in the epidemiological surveillance of Pseudomonas aeruginosa nosocomial infections.
    Fournier A; Voirol P; Krähenbühl M; Bonnemain CL; Fournier C; Pantet O; Pagani JL; Revelly JP; Dupuis-Lozeron E; Sadeghipour F; Pannatier A; Eggimann P; Que YA
    Burns; 2016 May; 42(3):564-70. PubMed ID: 26708236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
    Lee YJ; Liu HY; Lin YC; Sun KL; Chun CL; Hsueh PR
    Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
    Cook PP; Das TD; Gooch M; Catrou PG
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E; Zer Y; Eksi F
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
    Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
    Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibilities and clinical characterization of Pseudomonas aeruginosa isolates from urinary tract infections.
    Zhang X; Niu S; Zhang L
    Urol Int; 2014; 93(4):464-9. PubMed ID: 24642393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in antibiotic resistance in recurrent Pseudomonas aeruginosa infections of chronic suppurative otitis media.
    Song JJ; Lee BD; Lee KH; Lee JD; Park YJ; Park MK
    Ear Nose Throat J; 2016; 95(10-11):446-451. PubMed ID: 27792822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
    Xia J; Zhang D; Xu Y; Gong M; Zhou Y; Fang X
    Int J Infect Dis; 2014 Jun; 23():90-3. PubMed ID: 24726664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-drug resistant pseudomonas aeruginosa: a threat of nosocomial infections in tertiary care hospitals.
    Ali Z; Mumtaz N; Naz SA; Jabeen N; Shafique M
    J Pak Med Assoc; 2015 Jan; 65(1):12-6. PubMed ID: 25831667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.
    Keen EF; Murray CK; Robinson BJ; Hospenthal DR; Co EM; Aldous WK
    Infect Control Hosp Epidemiol; 2010 Jul; 31(7):728-32. PubMed ID: 20500036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of 2,252 Pseudomonas aeruginosa Clinical Isolates Over 4 Years to 9 Antimicrobials in a Tertiary Greek Hospital.
    Maraki S; Mantadakis E; Nioti E; Samonis G
    Chemotherapy; 2014; 60(5-6):334-41. PubMed ID: 26302835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.